Navigation Links
UC Irvine study finds racial, economic disparities in ovarian cancer care, survival
Date:5/8/2012

Orange, Calif., May 8, 2012 Poor women and African Americans with ovarian cancer are less likely to receive the highest standards of care, leading to worse outcomes than among white and affluent patients, according to a study of 50,000 women presented by UC Irvine's Dr. Robert Bristow at the Society of Gynecologic Oncology's annual meeting March 27.

"Not all women are benefiting equally from improvements in ovarian cancer care," said Bristow, UC Irvine's director of gynecologic oncology services. "The reasons behind these disparities are not entirely clear, which is why we need additional research."

The study's goal was to examine differences related to race and socioeconomic status among women being treated for epithelial ovarian carcinomas cancer that forms on the surface of an ovary. It also aimed to determine whether their care adhered to National Comprehensive Cancer Network treatment guidelines.

Bristow and colleagues found that five-year survival rates varied significantly. (Improvement in ovarian cancer care is measured in length of survival after diagnosis rather than a "cure" rate.)

Among those whose care met NCCN standards, the rate for white women was 41.4 percent, compared with 33.3 percent for African American women. Among those whose care did not meet NCCN standards, the rate for white women was 37.8 percent, compared with 22.5 percent for African American women.

Bristow said that women on Medicaid or those with no insurance had a 30 percent increased risk of death. Poor women defined as having an annual household income of less than $35,000 had worse survival rates regardless of race.

He said it's likely that the effects of race and socioeconomic status are cumulative and that some combination of other medical conditions, poverty, culture and social injustice accounts for the majority of observed disparities.

Ovarian cancer is the deadliest gynecologic cancer, accounting for more than 15,000 deaths a year, according to the National Cancer Institute.

"Under the best circumstances, treating ovarian cancer is challenging, because there's no screening tool available to detect the disease in its early stages," Bristow said.

Only 20 to 30 percent of ovarian cancers are diagnosed while still confined to the primary site; the remainder are identified in advanced stages after spreading to areas such as the liver, the lungs and nearby lymph nodes.


'/>"/>
Contact: John Murray
jdmurray@uci.edu
714-456-7759
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. UC Irvine Medical Center is recognized for its commitment to organ donation
2. UC Irvine Medical Center recognized for heart failure program
3. UC Irvine Medical Center honors 9 for nursing excellence
4. UC Irvine study points to new approach to influenzas antiviral resistance
5. UC Irvine researchers urge caution when buying noisy toys
6. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
7. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
8. TV drama can be more persuasive than news program, study finds
9. Study carried out into biological risks of eating reptiles
10. Neuroimaging study may pave way for effective Alzheimers treatments
11. Study finds racial gaps continue in heart disease awareness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with ... family-owned supermarket, has put together suggestions for enjoying the season of sunshine. Add trying ... everyone in the family can join in on the fun. , Try Something ...
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Greenfield Advisors is ... in the U.S. for the second year in a row. The Inc. 5000 list ... three years. , “To be on the list once is a great accomplishment, but ...
(Date:8/16/2017)... ... 2017 , ... The Data Council, the leading provider of ... by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, Natural ... suppliers, brokers, distributors and retailers. The Data Council will become a part of ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second year, the ... to educate the public on the impact of concussions. Brooke Mills, student and ... Concussion Awareness Day. , Brooke is working diligently is to raise awareness of ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County ... its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The ... disinfection robot that uses UVC light energy to kill deadly pathogens such as C. ... Tru-D SmartUVC ... Tru-D in action in ...
(Date:8/1/2017)... 1, 2017   CerSci Therapeutics , a non-opioid ... , has received notice from the National Institute ... Health (NIH) that it has been awarded a Direct-to-Phase ... $650,000 in 2017 with an additional $1,000,000 to follow ... Drug application of their lead non-opioid drug candidate CT-044 ...
Breaking Medicine Technology: